| Robust enumeration of cell subsets from tissue expression profiles AM Newman, CL Liu, MR Green, AJ Gentles, W Feng, Y Xu, CD Hoang, ... Nature methods 12 (5), 453-457, 2015 | 12425 | 2015 |
| Integrative analysis reveals selective 9p24. 1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and … MR Green, S Monti, SJ Rodig, P Juszczynski, T Currie, E O'Donnell, ... Blood, The Journal of the American Society of Hematology 116 (17), 3268-3277, 2010 | 1532 | 2010 |
| Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy MR Green, S Rodig, P Juszczynski, J Ouyang, P Sinha, E O'Donnell, ... Clinical cancer research 18 (6), 1611-1618, 2012 | 815 | 2012 |
| Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma P Caro, AU Kishan, E Norberg, IA Stanley, B Chapuy, SB Ficarro, K Polak, ... Cancer cell 22 (4), 547-560, 2012 | 616 | 2012 |
| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 615 | 2020 |
| Depleting tumor-specific Tregs at a single site eradicates disseminated tumors A Marabelle, H Kohrt, I Sagiv-Barfi, B Ajami, RC Axtell, G Zhou, ... The Journal of clinical investigation 123 (6), 2447-2463, 2013 | 500 | 2013 |
| Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation MR Green, S Kihira, CL Liu, RV Nair, R Salari, AJ Gentles, J Irish, H Stehr, ... Proceedings of the National Academy of Sciences 112 (10), E1116-E1125, 2015 | 424 | 2015 |
| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 400 | 2015 |
| Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma MR Green, AJ Gentles, RV Nair, JM Irish, S Kihira, CL Liu, I Kela, ... Blood, The Journal of the American Society of Hematology 121 (9), 1604-1611, 2013 | 394 | 2013 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 349 | 2023 |
| Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens MS Khodadoust, N Olsson, LE Wagar, OAW Haabeth, B Chen, ... Nature 543 (7647), 723-727, 2017 | 310 | 2017 |
| Immunodeficiency-associated lymphomas H Tran, J Nourse, S Hall, M Green, L Griffiths, MK Gandhi Blood reviews 22 (5), 261-281, 2008 | 225 | 2008 |
| Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer, R Nair, ... Blood, The Journal of the American Society of Hematology 137 (23), 3272-3276, 2021 | 215 | 2021 |
| Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma P Strati, S Ahmed, P Kebriaei, LJ Nastoupil, CM Claussen, G Watson, ... Blood Advances 4 (13), 3123-3127, 2020 | 210 | 2020 |
| TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis PM Dominguez, H Ghamlouch, W Rosikiewicz, P Kumar, W Béguelin, ... Cancer discovery 8 (12), 1632-1653, 2018 | 193* | 2018 |
| High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells JH Myklebust, JM Irish, J Brody, DK Czerwinski, R Houot, HE Kohrt, ... Blood, The Journal of the American Society of Hematology 121 (8), 1367-1376, 2013 | 192 | 2013 |
| Chromatin modifying gene mutations in follicular lymphoma MR Green Blood, The Journal of the American Society of Hematology 131 (6), 595-604, 2018 | 173 | 2018 |
| Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma P Mondello, S Tadros, M Teater, L Fontan, AY Chang, N Jain, H Yang, ... Cancer discovery 10 (3), 440-459, 2020 | 166 | 2020 |
| Rewiring cancer drivers to activate apoptosis S Gourisankar, A Krokhotin, W Ji, X Liu, CY Chang, SH Kim, Z Li, ... Nature 620 (7973), 417-425, 2023 | 147 | 2023 |
| Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas MA Lunning, MR Green Blood cancer journal 5 (10), e361-e361, 2015 | 132 | 2015 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of MedicineVerified email at stanford.edu
